Yue, Qun-Ying http://orcid.org/0000-0003-2475-2621
Caduff-Janosa, Pia http://orcid.org/0000-0002-5975-8858
Article History
Accepted: 8 February 2022
First Online: 2 March 2022
Declarations
:
: No sources of funding were used to assist the preparation of this study.
: The authors are indebted to the national centres that make up the WHO Programme for International Drug Monitoring and contribute reports to VigiBase. However, the opinions and conclusions of this study are not necessarily those of the various centres, nor of WHO.
: Qun-Ying Yue and Pia Caduff-Janosa have no conflicts of interest that are directly relevant to the content of this study.
: This article is result of routine work of Uppsala Monitoring Centre. Ethical approval was not required for this study. The reports shared within the WHO Programme are deidentified, and research based on this data is not subject to ethics approval or informed consent.
: Not applicable.
: Not applicable.
: The datasets generated and analysed during the current study are not publicly available due to agreements between contributors of data to the database used (VigiBase) and the custodian of this database. National centres (mainly national drug regulatory authorities) constituting the WHO Programme for International Drug Monitoring (PIDM) contribute data to VigiBase and the Uppsala Monitoring Centre is the custodian in its capacity as WHO collaborating centre for international drug monitoring. Some subsets of the data may be available from the corresponding author on reasonable request<b>.</b>
: Not applicable.
: Dr. Yue designed and performed the study, and wrote the paper. Dr Caduff-Janosa conceived the study and revised the manuscript content. Both authors approved the final version of the manuscript.